Bookmark and Share

Andrea  Berry

Andrea Berry M.D.

Academic Title: Assistant Professor
Primary Appointment: Pediatrics
Secondary Appointments: Medicine
Location: HSF-II, 480
Phone: (410) 706-1123
Phone: (410) 706-5328
Fax: (410) 706-6205

Personal History:

  • 1998: B.A. Biochemistry, Columbia College, New York
  • 2003: M.D. University of Pennsylvania School of Medicine
  • 2003-2006: Pediatrics Residency, The Children's Hospital of Philadelphia
  • 2006-2009: Pediatric Infectious Disease Fellowship, University of Maryland School of Medicine

Research Interests:

Dr. Berry's laboratory research focuses on the humoral immune response to malaria following natural infection and malaria vaccination.

Dr. Berry is the site Principal Investigator for pediatric vaccine trials conducted at the University of Maryland School of Medicine.

Clinical Speciality:

Pediatric Infectious Disease


  1. Chow AA, Moser CA, Speaker TJ, Offit PA. Determination of efficiency of attachment of biotinylated antibodies to avidin-linked, aqueous-based microcapsules by flow cytometry. J Immunol Methods, 277; 2003. 135-139.
  2. Berry SA, Johns B, Shih C, Berry AA, Walker DG. The cost effectiveness of rotavirus vaccination in Malawi. J Infect Dis, 202; 2010. S108-15. PMC3962285
  3. Yang Y, Berry AA, Lee W-C, Garnett JA, Marchant J, Levine JA, Simpson PJ, Fogel SA, Varney KM, Matthews SJ, Nataro JP, and Inman KG. Complete 1H, 13C and 15N NMR assignments for donor strand complemented AafA, the major pilin of aggregative adherence fimbriae (AAF/II) from enteroaggregative E. coli. J Biomol NMR Assign, 4; 2010. PMCID unavailable
  4. Travassos MA, Niangaly A, Bailey JA, Ouattara A, Coulibaly D, Laurens MB, Pablo J, Jasinskas A, Nakajima-Sasaki R, Berry AA, Takala-Harrison S, Kouriba B, Rowe JA, Lyke KE, Doumbo OK, Thera MA, Felgner PL, Plowe CV. Seroreactivity to the PfEMP1 intracellular domain in malaria-exposed children and adults, Journal of Infectious Diseases, 208(9); 2013. 1514-9. PMC3789569
  5. Murphy SC, Hermsen CC, Douglas AD, Edwards NJ, Petersen I, Fahle GA, Adams M, Berry AA, Billman ZP, Gilbert SC, Laurens MB, Leroy O, Lyke KE, Plowe CV, Seilie AM, Strauss KA, Teelen K, Hill AV, Sauerwein RW. External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance. PLOS One; 2014 May 16;9(5):e97398 PMC4023973
  6. Halasa NB, Gerber MA, Berry AA, Anderson EL, Winokur P, Keyserling H, Eckard AR, Hill H, Wolff MC, McNeal MM, Edwards KM, Bernstein DI. Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. Journal of the Pediatric Infectious Diseases Society 2014; doi: 10.1093/jpids/piu061
  7. Gandhi K, Thera MA, Coulibaly D, Traoré K, Guindo AB, Ouattara A, Takala-Harrison S, Berry AA, Doumbo OK, Plowe CV. Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications. PLoS One. 2014 Jul 3;9(7):e101783. doi: 10.1371/journal.pone.0101783. eCollection 2014. PubMed PMID: 24992338; PMC4081809.
  8. Berry AA, Yang Y, Pakharukova N, Garnett JA, Lee W, Cota E, Marchant J, Roy S, Tuittila M, Liu B, Inman KG, Ruiz-Perez F, Mandomando I, Nataro JP, Zavialov AV, Matthews  S. Structural insight into host recognition by aggregative adherence fimbriae of enteroaggregative Escherichia coli. PLoS Pathogens. 2014 Sep 18; 10(9):e1004404.